| Structure |
Chemical Name |
CAS |
MF |
 |
EVP 6124 |
550999-75-2 |
C16H17ClN2OS |
 |
Sarecycline Hydrochloride |
1035979-44-2 |
C24H30ClN3O8 |
 |
KML-29 |
1380424-42-9 |
C24H21F6NO7 |
 |
4H-1,2,4-Triazole-4-carboxaMide, 1-(2,4-dichlorophenyl) -N-(2,4-difluorophenyl)-1,5-dihydro-N-(1-Methylethyl)- 5-oxo- |
212201-70-2 |
C18H14Cl2F2N4O2 |
 |
Relugolix |
737789-87-6 |
C29H27F2N7O5S |
 |
VTX-2337 |
926927-61-9 |
C28H34N4O2 |
 |
TUG-770 |
1402601-82-4 |
C19H14FNO2 |
 |
AMD 070 hydrochloride |
880549-30-4 |
C21H28ClN5 |
 |
Azaphenonxazine dihydrochloride Monohydrate |
63302-99-8 |
C16H23Cl2N5O2 |
 |
CCT 241533 hydrochloride |
1431697-96-9 |
C23H28ClFN4O4 |
 |
CX 6258 hydrochloride hydrate |
1353858-99-7 |
C26H27Cl2N3O4 |
 |
LDE-225 Diphosphate |
1218778-77-8 |
C26H32F3N3O11P2 |
 |
LY-2795050 |
1346133-08-1 |
C23H22ClN3O2 |
 |
SodiuM Channel inhibitor 1 |
1198117-23-5 |
C24H19F4N3O3 |
 |
Tipiracil hydrochloride |
183204-72-0 |
C9H12Cl2N4O2 |
 |
CEP-28122 |
1022958-60-6 |
C28H35ClN6O3 |
 |
HMN 176 |
173529-10-7 |
C20H18N2O4S |
 |
HM 30181A |
849675-66-7 |
C38H36N6O7 |
 |
CTEP Derivative |
802906-73-6 |
C18H13ClFN3 |
![1H-Isoindole-1,3(2H)-dione, 5-[5-[[3-(4-broMophenyl)-2-iMino-4-oxo-5-thiazolidinylidene]Methyl]-2-furanyl]-](/CAS/20150408/GIF/1420071-30-2.gif) |
1H-Isoindole-1,3(2H)-dione, 5-[5-[[3-(4-broMophenyl)-2-iMino-4-oxo-5-thiazolidinylidene]Methyl]-2-furanyl]- |
1420071-30-2 |
C22H12BrN3O4S |
 |
PF-04995274 |
1331782-27-4 |
C23H32N2O6 |
 |
AC710 |
1351522-04-7 |
C31H42N6O4 |
 |
AgoMelatine (hydrochloride) |
1176316-99-6 |
C15H18ClNO2 |
 |
Ledipasvir (acetone) |
1441674-54-9 |
C52H60F2N8O7 |
 |
SP-420 |
911714-45-9 |
C16H21NO6S |
 |
Mps1-IN-2 |
1228817-38-6 |
C26H36N6O3 |
 |
QL47 |
1469988-75-7 |
C27H21N5O2 |
 |
PF-01247324 |
875051-72-2 |
C13H10Cl3N3O |
 |
AP-III-a4 |
1177827-73-4 |
C31H43FN8O3 |
 |
PSI-7976 |
1190308-01-0 |
C22H29FN3O9P |
 |
GSK2141795 |
1047634-65-0 |
C18H16Cl2F2N4O2 |
 |
NVP-TNKS656 |
1419949-20-4 |
C27H34N4O5 |
 |
N1-(2,2,6,6-tetraMethylpiperidin-4-yl)-N2-p-tolyloxalaMide |
144217-65-2 |
C18H27N3O2 |
 |
Optovin |
348575-88-2 |
C15H13N3OS2 |
 |
Resmetirom |
920509-32-6 |
C17H12Cl2N6O4 |
 |
Dafadine-A |
1065506-69-5 |
C23H25N3O3 |
 |
GK921 |
1025015-40-0 |
C21H20N4O |
 |
LDN-27219 |
312946-37-5 |
C20H16N4O2S2 |
 |
Skp2 Inhibitor C1 |
432001-69-9 |
C18H13BrN2O4S2 |
 |
Decernotinib |
944842-54-0 |
C18H19F3N6O |
 |
JIB-04 (NSC 693627) -Z |
199596-24-2 |
C17H13ClN4 |
 |
Eluxadoline Dihydrochloride |
864825-13-8 |
C32H39Cl2N5O5 |
 |
ERDAFITINIB |
1346242-81-6 |
C25H30N6O2 |
 |
N,N'-(2,2'-(1,4-phenylene)bis(ethane-2,1-diyl))dipropane-2-sulfonaMide |
380607-77-2 |
C16H28N2O4S2 |
 |
(S)-2-phenyl-1-(thiazol-2-yl)ethanaMine hydrochloride |
135383-60-7 |
C11H13ClN2S |
 |
CPI 360 |
1802175-06-9 |
C25H31N3O4 |
 |
IKK epsilon-IN-1 |
1292310-49-6 |
C26H27N5O3 |
 |
GV-58 |
1402821-41-3 |
C18H26N6OS |
 |
Z-360 |
209219-38-5 |
C29H36N4O5 |
 |
CX-4945 (sodiuM salt) |
1309357-15-0 |
C19H13ClN3NaO2 |
 |
Exherin (trifluoroacetate) |
1135237-88-5 |
C24H35F3N8O8S2 |
 |
Pyridoclax |
1651890-44-6 |
C29H22N4 |
 |
GSK2879552 |
1401966-69-5 |
C23H28N2O2 |
 |
CAS:932749-62-7 |
932749-62-7 |
C20H16Br2O3 |
![(S)-1-((5-chloropyridin-3-yl)methyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one](/CAS/GIF/1523406-39-4.gif) |
(S)-1-((5-chloropyridin-3-yl)methyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
1523406-39-4 |
C19H21ClF3N5O2 |
 |
ML-228 |
1357171-62-0 |
C27H21N5 |
 |
4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid |
1181226-02-7 |
C14H11Cl2NO4 |
 |
Wnt Agonist |
853220-52-7 |
C19H18N4O3 |
 |
N-(2-Aminophenyl)pyrazine-2-carboxamide |
926259-99-6 |
C11H10N4O |
 |
Theophylline-7-acetic acid |
652-37-9 |
C9H10N4O4 |
 |
PFK-158 |
1462249-75-7 |
C18H11F3N2O |
 |
CYM 50260 |
1355026-60-6 |
C14H11Cl3FNO2 |
 |
N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide |
1474110-21-8 |
C25H35NO5S |
 |
Epacadostat (INCB024360) |
1204669-58-8 |
C11H13BrFN7O4S |
![5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine](/CAS/20180702/GIF/1527503-11-2.gif) |
5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine |
1527503-11-2 |
C19H27N3O2 |
 |
ML346 |
100872-83-1 |
C14H12N2O4 |
 |
IN00076730 |
1454700-89-0 |
C17H21BrO2 |
 |
JH-II-127 |
1700693-08-8 |
C19H21ClN6O3 |
 |
A-196 |
1982372-88-2 |
C18H16Cl2N4 |
 |
ODM-201 |
1297538-32-9 |
C19H19ClN6O2 |
 |
GSK-2881078 |
1539314-06-1 |
C14H13F3N2O2S |
 |
Acamprosate calcium |
77337-73-6 |
C10H20CaN2O8S2 |
 |
JNJ 63533054 |
1802326-66-4 |
C17H17ClN2O2 |
 |
mk-1064 |
1207253-08-4 |
C24H20ClN5O3 |
 |
EPZ031686 |
1808011-22-4 |
C26H34ClF3N4O4S |
 |
RSL3 |
1219810-16-8 |
C23H21ClN2O5 |
 |
MS049 |
1502816-23-0 |
C15H24N2O |
 |
PIK-III |
1383716-40-2 |
C17H17N7 |
 |
ALS-8176 |
1445385-02-3 |
C18H25ClFN3O6 |
 |
SBI-0640756 |
1821280-29-8 |
C23H14ClFN2O2 |
 |
SirReal2 |
709002-46-0 |
C22H20N4OS2 |
 |
9-Propenyladenine |
1446486-33-4 |
C8H9N5 |
 |
SRT3025 |
1231952-55-8 |
C31H31N5O2S2 |
 |
BI-9564 |
1883429-22-8 |
C20H23N3O3 |
 |
CFMTI |
864864-17-5 |
C19H16FN5O |
 |
N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide |
1210608-43-7 |
C24H23F3N4O |
 |
APS-2-79 hydrochloride |
2002381-31-7 |
C23H22ClN3O3 |
 |
ml390 |
2029049-79-2 |
C21H21F3N2O3 |
 |
Amiselimod(MT-1303) free base |
942399-20-4 |
C19H30F3NO3 |
 |
NMS-P118 |
1262417-51-5 |
C20H24F3N3O2 |
 |
HDAC-IN-4 |
934828-12-3 |
C24H29N5O |
 |
MX-69 |
1005264-47-0 |
C27H26N2O4S |
 |
ASK1-IN-1 |
1262041-49-5 |
C23H21N7O |
 |
BAY41-4109 Racemic |
298708-79-9 |
C18H13ClF3N3O2 |
 |
MELK-8a |
1922153-17-0 |
C25H32N6O |
 |
1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(DIMETHYLAMINO)PROPAN-2-OL |
253449-04-6 |
C17H18Br2N2O |
 |
RO 31-8220 METHANESULFONATE |
125314-64-9 |
C25H23N5O2S |
 |
Deoxythymidine triphosphate |
18423-43-3 |
C10H18N2NaO14P3 |
 |
Testolactone |
968-93-4 |
C19H24O3 |
 |
O-304 |
1261289-04-6 |
C16H11Cl2N3O2S |